Sumitomo Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report

November 2023 | 50 pages | ID: S5DCD26858A1EN
MarketLine

Abstracts

Sumitomo Pharma Co., Ltd. %li%Strategy, SWOT and Corporate Finance Report

Summary

Sumitomo Pharma Co., Ltd. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Sumitomo Pharma Co., Ltd. (SPL or 'the company'), formerly Sumitomo Dainippon Pharma Co Ltd, a subsidiary of Sumitomo Chemical Co Ltd, is a developer, manufacturer, and importer of global pharmaceutical products. The company focuses on major therapeutic areas which include cardiovascular, central nervous system (CNS), diabetes, respiratory psychiatry, oncology and neurology and infectious diseases. It also offers research materials, food additives, chemical product materials, veterinary products, food ingredients, cosmetic materials, diagnostic agents, and other products. SPL also owns and operates manufacturing and distribution facilities, and research laboratories across Japan. It operates in countries across North America, the Asia Pacific and other regions of the world through its subsidiaries. The company is headquartered in Chuo-Ku, Osaka, Japan.

Scope

• Detailed information on Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis
• An in-depth view of the business model of Sumitomo Pharma Co., Ltd. including a breakdown and examination of key business segments
• Intelligence on Sumitomo Pharma Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Sumitomo Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Sumitomo Pharma Co., Ltd. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Sumitomo Pharma Co., Ltd. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Sumitomo Pharma Co., Ltd.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Sumitomo Pharma Co., Ltd.: Company Overview
Sumitomo Pharma Co., Ltd.: Overview and Key Facts
Sumitomo Pharma Co., Ltd.: Overview
Sumitomo Pharma Co., Ltd.: Key Facts
Sumitomo Pharma Co., Ltd.: Key Employees
Sumitomo Pharma Co., Ltd.: Key Employee Biographies
Sumitomo Pharma Co., Ltd.: Major Products and Services
Sumitomo Pharma Co., Ltd.: Management Statement
Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
Sumitomo Pharma Co., Ltd.: Key Competitors
Sumitomo Pharma Co., Ltd.: Company Analysis
Sumitomo Pharma Co., Ltd.: Business Description
Sumitomo Pharma Co., Ltd.: SWOT Analysis
Sumitomo Pharma Co., Ltd.: SWOT Overview
Sumitomo Pharma Co., Ltd.: Strengths
Sumitomo Pharma Co., Ltd.: Weaknesses
Sumitomo Pharma Co., Ltd.: Opportunities
Sumitomo Pharma Co., Ltd.: Threats
Sumitomo Pharma Co., Ltd.: Corporate Financial Deals Activity
Sumitomo Pharma Co., Ltd.: Financial Deals Overview
Sumitomo Pharma Co., Ltd.: Targets and Partners
Sumitomo Pharma Co., Ltd.: Top Deals 2019 - 2023YTD*
Sumitomo Pharma Co., Ltd.: Advisors
Sumitomo Pharma Co., Ltd.: Top Legal Advisors
Sumitomo Pharma Co., Ltd.: Top Financial Advisors
Sumitomo Pharma Co., Ltd.: Mergers and Acquisitions
Sumitomo Pharma Co., Ltd.: Corporate Venturing
Sumitomo Pharma Co., Ltd.: Capital Raising
Sumitomo Pharma Co., Ltd.: Partnership
Sumitomo Pharma Co., Ltd.: Divestments
Sumitomo Pharma Co., Ltd.: Recent Developments
Sumitomo Pharma Co., Ltd.: News and Events Summary
Sumitomo Pharma Co., Ltd.: Business Expansion
Sumitomo Pharma Co., Ltd.: Corporate Governance
Sumitomo Pharma Co., Ltd.: Financial Deals
Sumitomo Pharma Co., Ltd.: Financial Performance
Sumitomo Pharma Co., Ltd.: Market Developments
Sumitomo Pharma Co., Ltd.: Research & Development
Sumitomo Pharma Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Sumitomo Pharma Co., Ltd.: Key Facts
Table 2: Sumitomo Pharma Co., Ltd.: Key Employees
Table 3: Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
Table 4: Sumitomo Pharma Co., Ltd.: Key Competitors
Table 5: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 7: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 8: Sumitomo Pharma Co., Ltd.: Targets and Partners
Table 9: Sumitomo Pharma Co., Ltd.: Top Deals 2019 - 2023YTD*
Table 10: Sumitomo Pharma Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Sumitomo Pharma Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 12: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 13: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2019 - YTD*2023)
Table 14: Sumitomo Pharma Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 15: Sumitomo Pharma Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 16: Sumitomo Pharma Co., Ltd.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 17: Sumitomo Pharma Co., Ltd.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 18: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 19: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 20: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 21: Sumitomo Pharma Co., Ltd.: News and Events Summary
Table 22: Sumitomo Pharma Co., Ltd.: Business Expansion
Table 23: Sumitomo Pharma Co., Ltd.: Corporate Governance
Table 24: Sumitomo Pharma Co., Ltd.: Financial Deals
Table 25: Sumitomo Pharma Co., Ltd.: Financial Performance
Table 26: Sumitomo Pharma Co., Ltd.: Market Developments
Table 27: Sumitomo Pharma Co., Ltd.: Research & Development
Table 28: Sumitomo Pharma Co., Ltd.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Figure 4: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 5: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2019 - YTD*2023)
Figure 6: Sumitomo Pharma Co., Ltd.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 7: Sumitomo Pharma Co., Ltd.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 8: Sumitomo Pharma Co., Ltd.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 9: Sumitomo Pharma Co., Ltd.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 10: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 11: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 12: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2019 - YTD*2023)